The phenotype of CLL cells reveals multiple features characteristic of antigen-experienced, activated B lymphocytes, that utilize extensively BCR signaling-related molecules including aberrantly expressed ZAP-70 and CD38 [17], [31], [32]. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.